Animal Intestinal Health Market Size & Growth Forecast 2027–2036, By Segments (Animal Type, Product, Mode of Delivery, Function, Distribution Channel), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Animal Intestinal Health Market size stood at USD 5.55 billion in 2026 and is predicted to grow at a 8.59% CAGR from 2027 to 2036, reaching USD 12.65 billion by 2036. The industry revenue for 2027 is assessed at USD 5.95 billion.
Get more details on this report
Request Free Sample ReportAnimal Intestinal Health Market Intelligence Snapshot
Regional Market Dynamics
- Asia Pacific accounted for 34.45% of the market in 2026 and is also the fastest-growing region, driven by expanding livestock production, preventive animal healthcare, and demand for improved feed efficiency.
- Growing commercial livestock farming, increased awareness of animal diseases, and investment in modern animal husbandry are encouraging producers to adopt intestinal health solutions that support animal productivity and responsible antibiotic use.
Segment Momentum
- Production animals accounted for 71.71% of the market in 2026, reflecting livestock producers' focus on digestive health, feed efficiency, nutrient absorption, animal welfare, and productivity through preventive intestinal health management.
- Nutrition represented 81.93% of the market in 2026 and is also the fastest-growing segment, supported by demand for probiotics, prebiotics, enzymes, and specialized feed supplements that improve digestive function and nutrient utilization.
Market Expansion Drivers
- Rising demand for probiotics and feed additives.
- Expansion of intensive livestock farming.
- Research and innovation in gut health solutions.
Leading Market Participants
- Key players in the animal intestinal health market include Danisco/DuPont (USA), Chr. Hansen (Denmark), Novozymes (Denmark), Evonik (Germany), ADM (USA), BASF SE (Germany), DSM (Netherlands), Kemin Industries (USA), BIOMIN (Austria), Alltech (USA).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 5.55 billion
- 2027 Estimated Market Size: USD 5.95 billion
- Projected Market Size: USD 12.65 billion by 2036
- Growth Forecast: 8.59% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: Asia Pacific
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Animal Type (Production Animal) | Product (Nutrition) | Mode of Delivery (Feed/Water Additives) | Function (Preventive Care) | Distribution Channel (Animal Farms)
- Emerging Opportunity Segment: Animal Type (Production Animal) | Product (Nutrition) | Mode of Delivery (Feed/Water Additives) | Function (Preventive Care) | Distribution Channel (Animal Farms)
Market Growth Drivers and Industry Trends
Rising demand for probiotics and feed additives
Growing awareness of the relationship between intestinal health, animal performance, and overall productivity is driving demand for probiotics and functional feed additives. Livestock producers are increasingly adopting nutritional solutions that support beneficial gut microorganisms, improve digestive function, and help maintain animal health under changing production conditions. The shift toward preventive approaches to animal health is further encouraging the use of gut-focused feed solutions to support feed utilization, resilience, and consistent animal performance.
Expansion of intensive livestock farming
The expansion of intensive livestock production is increasing the need for effective intestinal health management as animals are raised in controlled environments at higher production densities. Intensive farming systems can create greater pressure on animal health and digestive stability, making nutritional management an important component of maintaining productivity and minimizing health-related disruptions. This is encouraging producers to adopt specialized feed strategies and intestinal health solutions that support digestion, microbial balance, and animal resilience.
Research and innovation in gut health solutions
Increasing research into the complex relationship between the gut microbiome, nutrition, immunity, and animal performance is supporting innovation in intestinal health solutions. Advances in nutritional science are enabling the development of more targeted probiotics, prebiotics, enzymes, and other functional ingredients designed to address specific digestive and physiological needs. Continued innovation is expanding the range of available solutions and encouraging livestock producers to incorporate scientifically developed intestinal health strategies into modern animal nutrition programs.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising demand for probiotics and feed additives | 1.5% | Medium term (2–5 yrs) | North America; Europe; Asia Pacific | Medium | Fast |
| Expansion of intensive livestock farming | 1.2% | Short term (≤ 2 yrs) | Asia Pacific; Latin America | Low | Fast |
| Research and innovation in gut health solutions | 1% | Long term (5+ yrs) | North America; Europe | Medium | Moderate |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
Asia Pacific (Largest & Fastest-Growing Region)
Asia Pacific accounted for a 34.45% share of the animal intestinal health market in 2026 and is also the fastest-growing region, supported by expanding livestock and poultry production, rising awareness of animal health, and increasing focus on improving animal productivity. The region's large animal population and growing demand for meat, dairy, and other animal-derived products are encouraging producers to adopt preventive health management practices focused on maintaining digestive and intestinal well-being. Increasing concerns regarding animal diseases, feed efficiency, and the responsible use of antibiotics are supporting demand for nutritional and health solutions that promote healthy gut function. Improvements in veterinary healthcare infrastructure and growing awareness among farmers and livestock producers are further strengthening market adoption. In addition, increasing investments in modern animal husbandry practices and the expansion of commercial livestock farming are creating favorable opportunities for intestinal health solutions across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Preventive Gut Health AdoptionThe U.S. animal intestinal health market is increasingly centered on preventive approaches spanning probiotics, feed additives, enzymes, and microbiome-supporting solutions. Commercial priorities include evidence-backed efficacy, integration into livestock nutrition programs, and products that help producers manage antibiotic-use pressures while maintaining animal performance.
Germany 🇩🇪
Evidence-Based Feed SolutionsGermany’s animal intestinal health market emphasizes scientifically validated feed solutions that support digestive function and responsible livestock production. Suppliers can differentiate through documented efficacy, formulation compatibility, and regulatory readiness, particularly for probiotic, prebiotic, and phytogenic products used within structured animal nutrition programs.
Japan 🇯🇵
Precision Livestock NutritionJapan’s animal intestinal health market favors targeted nutritional interventions that support animal performance, digestive stability, and production efficiency. Priorities include highly consistent formulations, functional feed ingredients, and microbiome-oriented solutions that can be incorporated into specialized diets for poultry, swine, and other intensively managed livestock.
South Korea 🇰🇷
Functional Feed InnovationSouth Korea’s animal intestinal health market is supported by growing interest in functional feed ingredients that improve digestive resilience and production outcomes. Market priorities include probiotic and postbiotic formulations, application-specific feed solutions, and products capable of demonstrating measurable benefits under intensive livestock production conditions.
France 🇫🇷
Sustainable Gut Health SolutionsFrance’s animal intestinal health market places emphasis on preventive nutrition and solutions compatible with more sustainable livestock production. Suppliers are likely to focus on natural functional ingredients, microbiome-supporting products, and validated alternatives that help maintain gut stability while aligning with evolving expectations around antibiotic stewardship.
Italy 🇮🇹
Specialty Animal NutritionItaly’s animal intestinal health market is shaped by demand for specialized nutritional solutions supporting digestive performance across livestock production systems. Commercial priorities include adaptable feed formulations, natural functional ingredients, and targeted probiotic or enzyme products that address specific intestinal-health needs without disrupting established feeding programs.
Animal Intestinal Health Market Share (%), by Animal Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduction Animal (Largest & Fastest-Growing Segment)
The production animal segment dominated the animal intestinal health market in 2026 with a 71.71% share, reflecting the increasing importance of gastrointestinal health in livestock productivity, feed efficiency, and overall animal performance. Production animals, including poultry, swine, cattle, and other livestock, require effective intestinal health management to maintain nutrient absorption, digestive functionality, and resistance to gastrointestinal disorders. The growing demand for animal-derived food products is encouraging livestock producers to adopt nutritional and preventive health strategies that support animal growth while improving production efficiency. Intestinal health solutions play an important role in maintaining a balanced gut microbiome, supporting immune function, and reducing the incidence of digestive complications that can negatively affect productivity. Furthermore, increasing awareness regarding the relationship between gut health, feed conversion, and animal welfare is encouraging producers to incorporate specialized feed additives, probiotics, prebiotics, and other nutritional interventions into livestock management programs. The growing emphasis on reducing dependence on antibiotic growth promoters is also strengthening demand for alternative intestinal health solutions. These developments are supporting the expansion of production animal applications while reinforcing their position as the fastest-growing animal type segment to gain more market share.
Nutrition (Largest & Fastest-Growing Segment)
In 2026, the nutrition segment accounted for the largest share of the animal intestinal health market, representing 81.93% of the overall market. The segment's dominance is supported by the essential role of nutritional interventions in maintaining digestive health, improving nutrient utilization, and supporting the overall performance of livestock and companion animals. Animal nutrition solutions, including probiotics, prebiotics, enzymes, organic acids, and specialized feed supplements, help maintain intestinal microbial balance and strengthen digestive functionality. Increasing awareness among livestock producers regarding the relationship between intestinal health and animal productivity is encouraging the adoption of targeted nutritional formulations. These products support better feed utilization, improve gastrointestinal resilience, and help animals cope with nutritional and environmental stress. Additionally, the growing shift toward preventive animal healthcare is strengthening demand for nutritional solutions that address intestinal health without relying exclusively on therapeutic treatments. Manufacturers are increasingly developing specialized formulations tailored to different animal species, production stages, and dietary requirements. The expanding adoption of functional feed ingredients and science-based animal nutrition strategies is further supporting the segment's continued growth, making nutrition a central component of intestinal health management to increase market share.
Feed/Water Additives (Largest & Fastest-Growing Segment)
Feed and water additives represented the largest segment of the animal intestinal health market, accounting for a 59.04% share in 2026. These delivery formats offer livestock producers a practical approach to incorporating intestinal health ingredients into routine feeding and drinking water management practices. Feed and water additives can be administered across animal populations without requiring individual treatment, making them particularly suitable for large-scale commercial farming operations. Their convenience and compatibility with existing livestock management systems support the adoption of probiotics, prebiotics, enzymes, organic acids, and other functional ingredients designed to maintain gastrointestinal balance. Additionally, consistent supplementation through feed and drinking water enables producers to implement preventive intestinal health programs while supporting nutrient absorption and animal performance. The increasing scale of commercial livestock production and growing awareness regarding gut microbiome management are further encouraging the use of these delivery methods. Manufacturers are also focusing on improving additive stability, palatability, formulation compatibility, and effectiveness under different feeding conditions. These advantages are reinforcing the importance of feed and water additives in animal intestinal health management while supporting their position as the fastest-growing delivery segment to capture market share.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Animal Type | Production Animal, Companion Animal | Production Animal | Production Animal |
| Product | Nutrition, Pharmaceuticals | Nutrition | Nutrition |
| Mode of Delivery | Feed/Water Additives, Supplements & Tablets, Others | Feed/Water Additives | Feed/Water Additives |
| Function | Preventive Care, Disease Treatment | Preventive Care | Preventive Care |
| Distribution Channel | Veterinary Hospitals/Clinics, Animal Farms, E-Commerce, Animal Specialty Stores, Others | Animal Farms | Animal Farms |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
As global livestock production faces increasing regulatory restrictions on prophylactic antibiotic growth promoters, competitive differentiation in the animal intestinal health market centers on robust scientific validation and manufacturing stability. Suppliers must demonstrate that alternative solutions—such as probiotics, prebiotics, and organic acids—consistently improve feed conversion and gut integrity under commercial conditions. A primary engineering hurdle is ensuring strain survivability, as active micro-organisms must endure intense heat and pressure during feed pelleting while maintaining viable counts throughout storage and gastrointestinal transit. Beyond strain survival, market leaders distinguish themselves by delivering mechanistic proof of microbiome modulation, providing livestock operators with verifiable, cost-effective performance gains across varying diets, animal ages, and management environments.
Major players in the animal intestinal health market:
- Danisco/DuPont (USA)
- Chr. Hansen (Denmark)
- Novozymes (Denmark)
- Evonik (Germany)
- ADM (USA)
- BASF SE (Germany)
- DSM (Netherlands)
- Kemin Industries (USA)
- BIOMIN (Austria)
- Alltech (USA)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Danisco/DuPont (USA) | |||||||
| Chr. Hansen (Denmark) | |||||||
| Novozymes (Denmark) | |||||||
| Evonik (Germany) | |||||||
| ADM (USA) | |||||||
| BASF SE (Germany) | |||||||
| DSM (Netherlands) | |||||||
| Kemin Industries (USA) | |||||||
| BIOMIN (Austria) | |||||||
| Alltech (USA) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Lesaffre | July 2025 | Lesaffre executed a strategic investment in CanBiocin to scale companion animal microbiome capabilities and extend distribution into veterinary channels. |
| Dechra | May 2025 | Dechra launched Catney One, a feline kidney health supplement utilizing lanthanum carbonate to reduce phosphate absorption as a calcium-free treatment alternative. |
| Kemin Industries | May 2025 | Kemin Industries acquired Bactana to scale internal fermentation and microbiome research capabilities for multi-species probiotic and postbiotic nutrition programs. |
| Boehringer Ingelheim Animal Health | March 2025 | Boehringer Ingelheim Animal Health, in collaboration with research partners, developed the probiotic strain Lactobacillus johnsonii CNCM I-4884, demonstrating enhanced resistance to digestive processes and superior efficacy against Giardia intestinalis. |
| Kent Nutrition Group | December 2024 | Kent Nutrition Group and research partners developed a novel Bacillus-based probiotic designed to enhance digestion and gut health in poultry and swine operations. |
| Amlan International | October 2024 | Amlan International established a strategic distribution partnership with VetPro to commercialize animal health additives, including Calibrin-Z and Varium, across northern Brazil. |
| General Mills | November 2023 | General Mills acquired Fera Pets to establish a commercial footprint in pet care supplements, combining scientific formulations with Eastern and Western medical approaches. |
| DSM-Firmenich | July 2023 | DSM-Firmenich completed the acquisition of postbiotic specialist Adare Biome to expand its portfolio capabilities and accelerate the commercialization of next-generation biotics. |
| Evonik | November 2020 | Evonik launched Ecobiol Fizz, an effervescent tablet formulation containing Bacillus amyloliquefaciens to stabilize the intestinal microbiota of chickens during high-stress periods. |
| Kemin Industries | January 2020 | Kemin Industries introduced a proprietary phytogenic feed additive designed as a cost-effective solution for poultry producers to mitigate the operational impact of enteric diseases. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Animal Intestinal Health Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Disease Condition | Gastrointestinal Infections, Diarrhea & Digestive Disorders, Parasitic Infections, Microbiome-Related Disorders, Other Intestinal Conditions |
| Life Stage | Neonatal/Young Animals, Growing Animals, Adult Animals, Senior Animals |
| Payer Type | Commercial Producers, Veterinary Practices & Hospitals, Pet Owners, Government & Institutional Buyers |
Animal Intestinal Health Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Gut Health Intervention Pathways |
|
| Feed Additive Adoption Economics |
|
| Farm-Level Adoption Barriers & Solutions |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
What is the overall size of the animal intestinal health market?
What is the anticipated CAGR of the animal intestinal health industry?
How is the shift toward preventive animal health shaping demand for intestinal health solutions?
How is intensive livestock production influencing investment in gut health solutions?
Why does the production animal segment dominate the animal intestinal health market?
How are nutritional solutions driving growth in the animal intestinal health market?
Why does Asia Pacific dominate the animal intestinal health market?
How are changing livestock production practices supporting animal intestinal health demand in Asia Pacific?
Which companies are driving growth in the animal intestinal health landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook